Gloria M. Lopez-Rodriguez
Mexico City, DIF, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
In Silico Molecular Docking Analysis of Valproic Acid as an Inhibitor of Bruton's Tyrosine Kinase: Potential Drug Repurposing for Allergies.
Journal: Cureus
Published: August 17, 2025
Brucella abortus induces mast cell activation through TLR-2 and TLR-4.
Journal: Microbial pathogenesis
Published: June 17, 2022
Valproic acid restricts mast cell activation by Listeria monocytogenes.
Journal: Scientific reports
Published: February 25, 2022
Severe COVID-19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin.
Journal: Journal of leukocyte biology
Published: February 02, 2021
TLR2 Regulates Mast Cell IL-6 and IL-13 Production During Listeria monocytogenes Infection.
Journal: Frontiers in immunology
Published: January 08, 2021
The histone deacetylase inhibitor valproic acid attenuates phospholipase Cγ2 and IgE-mediated mast cell activation.
Journal: Journal of leukocyte biology
Published: December 09, 2019
Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells.
Journal: Journal of immunology research
Published: August 29, 2018
Mycobacterium tuberculosis Catalase Inhibits the Formation of Mast Cell Extracellular Traps.
Journal: Frontiers in immunology
Published: February 10, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026